炎症相关指标对高增殖活性胃肠神经内分泌肿瘤预后的价值分析
Analysis of the Prognostic Value of Inflammation-Related Biomarkers in Gastrointestinal Neuroendocrine Neoplasms with High Proliferative Activity
DOI: 10.12677/acm.2025.152437, PDF,   
作者: 郭梦迪, 刘金月:青岛大学青岛医学院,山东 青岛;王十锦, 荆 雪, 江月萍*:青岛大学附属医院消化内科,山东 青岛
关键词: 胃肠神经内分泌肿瘤炎症指标预后Gastrointestinal Neuroendocrine Neoplasms Inflammatory Markers Prognosis
摘要: 目的:探讨炎症相关指标在高增殖活性胃肠神经内分泌肿瘤预后中的临床意义,为其患者的预后提供参考依据。方法:回顾性分析青岛大学附属医院2017~2022年48例高增殖活性胃肠神经内分泌肿瘤患者的临床资料,采用Cox回归模型进行单因素及多因素分析,Kaplan‑Meier方法进行生存分析。结果:单因素Cox回归模型显示高血压病史、肝转移、NLR、GLR是预后的影响因素(P < 0.05),多因素Cox回归模型结果显示,NLR升高、肝转移是预后的独立危险因素(P < 0.05);Kaplan‑Meier生存分析结果表明,NLR高组、GLR高组患者的生存期较短。结论:NLR、GLR对高增殖活性胃肠神经内分泌肿瘤患者预后有预测价值。
Abstract: Objective: This study aims to explore the clinical significance of inflammation-related biomarkers in predicting the prognosis of high-proliferative gastrointestinal neuroendocrine neoplasms (GI-NENs), thereby providing a reference for patient management. Methods: A retrospective analysis was conducted on the clinical data of 48 patients diagnosed with high-proliferative GI-NENs at the Affiliated Hospital of Qingdao University between 2017 and 2022. Univariate and multivariate Cox regression models were employed to identify prognostic factors, while Kaplan-Meier survival analysis was used to evaluate survival outcomes. Results: The univariate Cox regression analysis revealed that hypertension history, liver metastasis, neutrophil-to-lymphocyte ratio (NLR), and glycoprotein acetylation ratio (GLR) were significant predictors of prognosis (P < 0.05). Multivariate Cox regression analysis further indicated that NLR and liver metastasis were independent risk factors for poor prognosis (P < 0.05). Kaplan-Meier survival curves demonstrated that patients with elevated NLR and GLR had significantly shorter survival times. Conclusion: Both NLR and GLR serve as valuable indicators for predicting the prognosis of patients with high-proliferative GI-NENs.
文章引用:郭梦迪, 王十锦, 刘金月, 荆雪, 江月萍. 炎症相关指标对高增殖活性胃肠神经内分泌肿瘤预后的价值分析[J]. 临床医学进展, 2025, 15(2): 997-1004. https://doi.org/10.12677/acm.2025.152437

参考文献

[1] Dasari, A., Shen, C., Halperin, D., Zhao, B., Zhou, S., Xu, Y., et al. (2017) Trends in the Incidence, Prevalence, and Survival Outcomes in Patients with Neuroendocrine Tumors in the United States. JAMA Oncology, 3, 1335-1342. [Google Scholar] [CrossRef] [PubMed]
[2] Ptasnuka, M., Ozolins, A., Narbuts, Z., Truskovs, A., Sperga, M. and Plaudis, H. (2019) Epidemiological Data and Treatment of Gastroenteropancreatic Neuroendocrine Neoplasms: Insights from Tertiary Referral Hospitals in Latvia. World Journal of Surgery, 44, 585-593. [Google Scholar] [CrossRef] [PubMed]
[3] Nagtegaal, I.D., Odze, R.D., Klimstra, D., Paradis, V., Rugge, M., Schirmacher, P., et al. (2019) The 2019 WHO Classification of Tumours of the Digestive System. Histopathology, 76, 182-188. [Google Scholar] [CrossRef] [PubMed]
[4] Genç, C.G., Falconi, M., Partelli, S., Muffatti, F., van Eeden, S., Doglioni, C., et al. (2018) Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67. Annals of Surgical Oncology, 25, 2467-2474. [Google Scholar] [CrossRef] [PubMed]
[5] Lin, N., Li, J., Yao, X., Zhang, X., Liu, G., Zhang, Z., et al. (2022) Prognostic Value of Neutrophil-To-Lymphocyte Ratio in Colorectal Cancer Liver Metastasis: A Meta-Analysis of Results from Multivariate Analysis. International Journal of Surgery, 107, Article ID: 106959. [Google Scholar] [CrossRef] [PubMed]
[6] Cui, L., Yu, F., Cheng, Z., Su, F., Chen, Y. and Tan, H. (2024) Prognostic Value of Inflammation‐Related Biomarkers in Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Systematic Review and Meta‐Analysis. Journal of Neuroendocrinology, 36, e13381. [Google Scholar] [CrossRef] [PubMed]
[7] Giannetta, E., La Salvia, A., Rizza, L., Muscogiuri, G., Campione, S., Pozza, C., et al. (2021) Are Markers of Systemic Inflammatory Response Useful in the Management of Patients with Neuroendocrine Neoplasms? Frontiers in Endocrinology, 12, Article 672499. [Google Scholar] [CrossRef] [PubMed]
[8] Yamamoto, T., Kawada, K. and Obama, K. (2021) Inflammation-related Biomarkers for the Prediction of Prognosis in Colorectal Cancer Patients. International Journal of Molecular Sciences, 22, Article 8002. [Google Scholar] [CrossRef] [PubMed]
[9] 魏智民, 孙玉发, 李刚, 等. 癌症相关性炎症与肿瘤微环境相关研究进展[J]. 中国肿瘤临床, 2018, 45(21): 1117-1121.
[10] Greten, F.R. and Grivennikov, S.I. (2019) Inflammation and Cancer: Triggers, Mechanisms, and Consequences. Immunity, 51, 27-41. [Google Scholar] [CrossRef] [PubMed]
[11] Pozza, A., Pauletti, B., Scarpa, M., Ruffolo, C., Bassi, N. and Massani, M. (2019) Prognostic Role of Neutrophil-To-Lymphocyte Ratio and Platelet-To-Lymphocyte Ratio in Patients with Midgut Neuroendocrine Tumors Undergoing Resective Surgery. International Journal of Colorectal Disease, 34, 1849-1856. [Google Scholar] [CrossRef] [PubMed]